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Volume 57, Number 5S Abstracts 81Sthrough retro-orbital injection at two different dosages,
0.75gI/kg and 2.75gI/kg. PBS was given to the mice in
control group. Mice kidneys were harvested at day 3 and
day 7 following Iodixanol administration. RNA and
protein were then extracted. qRT -PCR and Western
blot were used to quantify A1AR, A2AAR, A2BAR, and
A3AR RNA and protein expression respectively, with
GAPDH as endogenous control.
Results: qRT-PCR showed that Iodixanol induced
AR transcription, speciﬁcally in the group treated with
2.75gI/kg at day 3 after injection. The RNA levels in all
the four subtypes of ARs were increased 2-3 folds at day
3, but returned to normal at day 7 in Iodixanol groups
compared to PBS controls. The Western blot results
showed that A1AR, A2AAR, A3AR expressions were
increased 1.5-2 folds in Iodixanol group at day 3 compare
to PBS control. A2BAR expression was very low in normal
physiological condition and no signiﬁcant changes were
detected by western blot.
Conclusions: Our results indicate that Iodixanol
induces adenosine receptor gene expression in mice. Aden-
osine receptors may play a role in the development of CIN.
Further investigation on the correlation between adenosine
receptor gene expression and severity of CIN will be
preformed.
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Omaida C. Velazquez. Surgery, Univ Miami, Miami, Fla
Objectives: Wnt-induced secreted protein-1 (WISP-
1/CCN4) is involved in regulating cell proliferation,
survival/apoptosis, migration and tumor growth. We
previously observed that tumor stroma-produced WISP-
1/CCN4 plays a critical role in melanoma growth and
tumor angiogenesis. We sought to determine the biologic
effect of WISP-1/CCN4 on endothelial cell biology and
angiogenesis.
Methods: The effects of WISP-1/CCN4 on cell
growth and migration of human endothelial cells (EC)
were examined by MTT and transwell-migration assay.
Two- and three-dimensional (2D and 3D) angiogenesis
models were used to study the role of WISP-1/CCN4 in
vascular network formation of EC. Melanoma xenograft
murine model was employed to examine the biological
effect of WISP-1/CCN4 on tumor angiogenesis and
growth. Human melanoma cells transduced with WISP-
1/lentivirus or GFP/lentivirus were xenografted on skin
of SCID mice (n ¼ 6/group). Expression of exogenous
WISP-1/CCN4 in transduced melanoma cells was vali-
dated by Western blot. Tumor angiogenesis was assessed
by mouse whole-body Dil-perfusion and tumor tissue
confocal microscopy. Tumor size was measured to deter-
mine tumor growth.Results: WISP-1/CCN4 inhibited cell growth and
migration of EC in vitro. Vascular network formation of
EC in 2D- and 3D angiogenesis models was suppressed
considerably (P < .01) by supplementation of ghWISP-1
(100 ng/mL) in both Matrigel (2D) and type I collagen
gel (3D). Elevated expression of WISP-1 in tumor tissue
signiﬁcantly antagonized tumor angiogenesis and retarded
tumor growth in vivo.
Conclusions: Our results revealed a novel role of
WISP-1/CCN4 in negatively regulating endothelial cell
biology and angiogenesis, implicating that WISP-1/
CCN4 may serve as a novel target for cancer therapeutic
intervention.
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Objectives: Patients with critical limb ischemia (CLI)
have attributable myopathy that impairs their functional
ability as well as dampening the positive effect of successful
revascularization outcomes. Adult skeletal muscle retains
the potential to repair following different injury patterns.
We aim to investigate the potential differences in prolifera-
tion and migration capability of human myoblasts with CLI
and asymptomatic control patients.
Methods: Gastrocnemius muscle biopsies were ob-
tained from patients with critical limb ischemia and control
samples were obtained from non-ischemic patients.
Human myoblasts were isolated and cultured from each
sample and stained with the myoblast marker desmin.
Conﬁrmed myoblast cultures (<5% alternative cell type
contamination) were then used to investigate the prolifera-
tive capability (MTT assay) as well as migratory potential
(scratch-wound assay) under both ischemic and normoxic
conditions of each group.
Results: Myoblasts isolated from CLI patients
demonstrated greater proliferative ability in comparison
to control samples. However, control samples revealed
greater capacity to heal scratch wounds made in a mono-
layer of myoblasts in both normoxia and hypoxic
conditions.
Conclusions: Isolation of human myoblasts, especially
from disease groups provides a useful platform to perform
in vitro analysis to better understand and characterise
pathology. CLI myoblasts exhibited enhanced proliferative
but diminished migratory potential in comparison to
control myoblasts.
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